UNSPSC 41142045: Prolactin (lactogen) test system

In this classification, Prolactin (lactogen) test system connotes a device used to measure Prolactin (lactogen) levels. US FDA regulates Prolactin (lactogen) test system under 21 CFR 862.1625 and under FDA product code CFS.

UNSPSC 41142045 Prolactin (lactogen) test system is a Commodity code that in recent state and local practice encompasses forensic drug analysis reagents, certified reference materials (drug standards), and related laboratory consumables for toxicology and seized-drug testing operations. The Texas Department of Public Safety, Texas Department of Criminal Justice, Texas Health and Human Services Commission (on behalf of the Department of State Health Services), Pinellas County Florida, and Illinois Department of Financial and Professional Regulation are the issuing bodies visible in recent solicitations. Work spans Direct ELISA testing kits for substance screening (cannabinoids, opiates, PCP, amphetamines, benzodiazepines, cocaine, and related compounds), certified reference materials meeting ISO/IEC 17025:2017 and ISO 17034:2016 accreditation with purity exceeding 97%, DNA screening and sizing kits, and related laboratory analytical equipment and supplies. Pinellas County's procurement includes a Certified Small Business Enterprise preference with five-day filing priority and a subsequent five percent price preference, and is funded in part through the Paul Coverdell Forensic Sciences Improvement Act Program. Texas procurements require Historically Underutilized Business subcontracting plans covering women-owned, minority-owned, and service-disabled veteran-owned business categories.

Recent activity concentrates in Texas and Florida. The Texas Department of Public Safety issued IFB 405-26R0008445A for immunalysis reagent kits (12 line items, 3–30 units per item) with electronic bids due July 23, 2026. Pinellas County, Florida, solicited certified drug standards via ITQ 26-0305-ITQ (131 line items, due April 23, 2026, funded with $72,126.85 in federal Paul Coverdell grant funds, approximately $49,034.00 for supplies). The Texas Health and Human Services Commission issued IFB HHS0016902v2 for QIAxcel and QIAamp DNA screening kits (seven line items including kits, markers, and supplies, with historical annual spend of $25,050–$30,000, initial term through August 31, 2026). The Illinois Department of Financial and Professional Regulation established a joint purchase master contract for mosquito testing equipment (RAMP System including West Nile Virus and Dengue test kits) via sole source to ADAPCO, LLC, with notice of intent posted May 4, 2026. Contract terms typically run one year with extension options, and most solicitations require firm pricing for the contract duration and compliance with financial documentation, debarment certifications, and state-specific vendor registration requirements.